$19.0M
Cross-Border Impact Ventures led the round, which will fund international expansion and product development.
TidalSense manufactures handheld diagnostic devices that detect chronic obstructive pulmonary disease from normal breathing.
Cambridge-based medical technology company developing handheld diagnostic tools for respiratory conditions.
Cash at bank
Net current assets
Total assets less current liabilities
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from TidalSense's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Ameera Patel
Chief executive
Julian Carter
Cross-Border Impact Ventures led the round, which will fund international expansion and product development.
The funding round was led by BGF and Downing to support the rollout of the company's respiratory diagnostics business.